Free Trial

Check-Cap Q3 2023 Earnings Report

Check-Cap logo
$0.59 +0.02 (+3.44%)
(As of 12/20/2024 05:31 PM ET)

Check-Cap Earnings Headlines

StockNews.com Initiates Coverage on Check-Cap (NASDAQ:CHEK)
⭕ [URGENT] Buy Alert just triggered
My absolute favorite stock just hit a critical "buy now" trigger price.
What Is Market Cap and Why Does It Matter?
See More Check-Cap Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Check-Cap? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Check-Cap and other key companies, straight to your email.

About Check-Cap

Check-Cap (NASDAQ:CHEK), a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.

View Check-Cap Profile

More Earnings Resources from MarketBeat

Upcoming Earnings